Former director general: Health Canada needs broader drug safety powers
- Health Canada drug approval process slower than in Europe and US. // British Columbia Medical Journal;Jun2013, Vol. 55 Issue 5, p234
The article deals with a report the Fraser Institute which revealed that the drug approval process by Health Canada takes nearly a year which is slower than in Europe and the U.S.
- Unauthorised products warning in Canada. // Reactions Weekly;2/27/2010, Issue 1290, p4
The article reports on a warning issued by Health Canada to customers about unauthorised products sold under the "OM Fusion Distributors LLC" label stating that the products may cause life threatening reactions.
- New table helps generic co.'s keep safety labelling up to date. // Reactions Weekly;3/16/2013, Issue 1444, p5
The article reports that the Health Canada launched a table on its website focused on informing generic drug manufacturers about the safety labelling changes to the Product Monographs, pharmaceutical brand.
- Antipsychotics and newborns. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;8/9/2011, Vol. 183 Issue 11, pE721
The article reports that Canada's Health Canada is following the U.S. lead and revised labelling requirements for a class of antipsychotic drugs being used during pregnancies.
- Pricing Under Microscope. // Chain Drug Review;7/19/2010, Vol. 32 Issue 12, p64
The article reports on the release of the discussion paper "Generic Drug Pricing and Access in Canada: What are the Implications?" by the Health Council of Canada.
- Health Canada Releases Resource Kit To Assist Health Professionals. . // Journal of the Canadian Dental Association;Sep1998, Vol. 64 Issue 8, p548
The article focuses on the resource kit entitled "Medication Matters: How You Can Help Seniors Use Medication Safely" published by the agency Health Canada.
- Health Canada issues reminder of benzocaine risks. // Reactions Weekly;5/7/2011, Issue 1350, p3
This article reports on the move of Health Canada to remind the people of the risks associated with the use of topical benzocaine.
- Health Canada seeks policy on DEHP. // Plastics News;2/18/2002, Vol. 13 Issue 50, p3
Reports Health Canada recommendation on the usage and exposure of di(2-ethylhexyl)phthalate (DEHP) in Toronto, Ontario. Advisory panel of medical professionals on DEHP regulation; Use of DEHP; Concerns on the health of patients.
- Health Canada cracks down on poppers. SALERNO, ROB // Xtra West (Vancouver);7/18/2013, Issue 519, p12
The article reports on the warning of Health Canada regarding the sale of alkyl nitrate products, known as poppers, which classified as a drug under the Food and Drug Act, in Canada in 2013.